- Filed
- Nov 3, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Nov 1, 2021 | 31.75M sh |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $122.37M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $177.91M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $185.15M |
| Current Assets | Q3 2021 · Dec 31, 2020 | $262.31M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $370.44M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $454.21M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $84.35M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2020 | $95.78M |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 31.56M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 31.47M sh |
| Capex | Q3 2021 · Sep 30, 2020 | $4.13M |
| Operating Cash Flow | Q3 2021 · Sep 30, 2020 | $62.04M |
| Stockholders Equity | Q3 2021 · Sep 30, 2020 | $207.56M |
| Stockholders Equity | Q3 2021 · Jun 30, 2020 | $204.11M |
| Stockholders Equity | Q3 2021 · Mar 31, 2020 | $200.61M |
| Stockholders Equity | Q3 2021 · Dec 31, 2019 | $119.98M |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | $0.12 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | −$0.33 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | $0.12 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | −$0.33 |
| Sga Expense restated | Q3 2021 · Sep 30, 2020 | $19.77M |
| Sga Expense restated | Q3 2021 · Sep 30, 2020 | $65.05M |
| Operating Income | Q3 2021 · Sep 30, 2020 | $3.69M |
| Operating Income | Q3 2021 · Sep 30, 2020 | $13.66M |